GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells

The malignant phenotype of chronic myeloid leukemia (CML) is due to the abnormal tyrosine kinase activity of the BCR-ABL oncoprotein, which signals several downstream cell survival pathways, including phosphoinositide 3-kinase/AKT, signal transducer and activator of transcription 5 and extracellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Joha, S, Nugues, A-L, Hétuin, D, Berthon, C, Dezitter, X, Dauphin, V, Mahon, F-X, Roche-Lestienne, C, Preudhomme, C, Quesnel, B, Idziorek, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312406/
https://www.ncbi.nlm.nih.gov/pubmed/21804606
http://dx.doi.org/10.1038/onc.2011.328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312406/
https://www.ncbi.nlm.nih.gov/pubmed/21804606
http://dx.doi.org/10.1038/onc.2011.328

Ejemplares similares